ADAM17 and idiopathic pulmonary fibrosis: ADAM17 mRNA was not changed between all groups (Fig. 7c), and there was a trend to reduced TIMP3 mRNA (p = 0.084) in IPF patients compared to other groups (Fig. 7d).